Trabectedin (Yondelis®) in Soft Tissue SarcomaZINTL, Patrik; SANTABARBARA, Pedro.Methods and findings in experimental and clinical pharmacology. 2008, Vol 30, pp 29-31, issn 0379-0355, 3 p., SUP2Conference Paper

Erlotinib in previously treated non-small-cell lung cancerSHEPHERD, Frances A; PEREIRA, José Rodrigues; VAN KOOTEN, Maximiliano et al.The New England journal of medicine. 2005, Vol 353, Num 2, pp 123-132, issn 0028-4793, 10 p.Article

Determinants of tumor Response and survival with erlotinib in patients with non-small-cell lung CancerPEREZ-SOLER, Roman; CHACHOUA, Abraham; HAMMOND, Lisa A et al.Journal of clinical oncology. 2004, Vol 22, Num 16, pp 3238-3247, issn 0732-183X, 10 p.Article

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international studyKEATING, Michael J; FLINN, Ian; RAI, Kanti R et al.Blood. 2002, Vol 99, Num 10, pp 3554-3561, issn 0006-4971Article

Phase I Pharmacokinetic trial and correlative in vitro Phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drugALBERTS, David S; HALLUM, Alton V; STRATTON-CUSTIS, Mary et al.Clinical cancer research. 2001, Vol 7, Num 5, pp 1246-1250, issn 1078-0432Article